New hope for Muscle-Weakening disease: multiple drug trials launch
NCT ID NCT07294170
Summary
This study aims to test the safety and effectiveness of several different drug combinations for people with myasthenia gravis, a condition that causes muscle weakness. It will enroll about 70 adults who have been diagnosed with the disease and are on stable treatment. The goal is to find better ways to manage symptoms and improve quality of life by trying different medication approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dent Neurologic Institute - Amherst
RECRUITINGAmherst, New York, 14226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Erlanger Health System
RECRUITINGColumbia, Maryland, 21044, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Neuromuscular Research Institute
RECRUITINGAustin, Texas, 78759, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Profound Research LLC - Carlsbad
RECRUITINGCarlsbad, California, 92011, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Visionary Investigators Network
RECRUITINGMiami, Florida, 33133, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.